BS
CVS icon

Boenning & Scattergood’s CVS Health CVS Stock Holding History

Boenning & Scattergood’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$6.75M Buy
66,739
+869
+1% +$83.9K 1.09% 12
2022
Q3 		$6.28M Sell
65,870
-1,094
-2% -$108K 1.28% 10
2022
Q2 		$6.21M Buy
66,964
+225
+0.3% +$22K 1.17% 14
2022
Q1 		$6.75M Sell
66,739
-9,213
-12% -$968K 1.09% 12
2021
Q4 		$7.83M Sell
75,952
-736
-1% -$68K 1.25% 10
2021
Q3 		$6.51M Sell
76,688
-766
-1% -$64.2K 1.14% 13
2021
Q2 		$6.46M Sell
77,454
-9,048
-10% -$741K 1.13% 12
2021
Q1 		$6.51M Sell
86,502
-5,658
-6% -$412K 1.24% 10
2020
Q4 		$6.29M Buy
92,160
+5,867
+7% +$382K 1.33% 10
2020
Q3 		$5.04M Sell
86,293
-8,743
-9% -$544K 1.21% 15
2020
Q2 		$6.17M Buy
95,036
+17,348
+22% +$1.09M 1.65% 9
2020
Q1 		$4.61M Buy
77,688
+3,552
+5% +$237K 1.59% 11
2019
Q4 		$5.51M Sell
74,136
-12,219
-14% -$858K 1.42% 12
2019
Q3 		$5.45M Buy
86,355
+4,161
+5% +$247K 1.57% 12
2019
Q2 		$4.48M Buy
82,194
+6,366
+8% +$343K 1.31% 15
2019
Q1 		$4.09M Buy
75,828
+27,074
+56% +$1.67M 1.22% 16
2018
Q4 		$3.19M Buy
48,754
+12,431
+34% +$928K 1.11% 18
2018
Q3 		$2.86M Sell
36,323
-1,629
-4% -$116K 0.91% 24
2018
Q2 		$2.44M Buy
+37,952
New +$2.5M 0.8% 25

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boenning & Scattergood's CVS Position: Q4 2022 in Review

Boenning & Scattergood increased its CVS Health (CVS) stake by 1.3% in Q4 2022, buying an estimated $83.9K and bringing the position to 66,739 shares worth $6.75M. The position accounts for 1.09% of the portfolio, ranked #12.

Boenning & Scattergood first reported a position in CVS in Q2 2018 and has held it in 19 quarters since. The position peaked at $7.83M in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Boenning & Scattergood held 66,739 shares of CVS Health worth $6.75M as of Q4 2022.
  • Boenning & Scattergood bought 869 CVS Health shares in Q4 2022, an estimated $83.9K.
  • CVS Health made up 1.09% of Boenning & Scattergood's portfolio in Q4 2022, its #12 holding.
  • Boenning & Scattergood first reported a position in CVS Health in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's CVS Health position peaked at $7.83M in Q4 2021.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.